Purpose of Review: Obstructive sleep apnea (OSA) and hypertension are two phenomena deeply linked together and, although a causal relationship has been suggested, a recent meta-analysis showed only a very modest effect of OSA treatment on blood pressure (BP). However, a vast number of randomized controlled trials published so far share some limitations, mainly of methodological nature: neither OSA nor BP is always assessed in a standardized way. Moreover, compliance with OSA treatment is often sub-optimal making the results of these trials difficult to interpret. Recent Findings: Recent studies have shown that antihypertensive drugs can reduce BP more than OSA treatment, showing a better compliance profile and very few side effects. Summary: Considering the importance of reducing the overall cardiovascular risk of OSA patients, a more careful management of patient’s antihypertensive medication could allow a better BP control also in this condition. In addition, greater efforts should be made to improve patient’s acceptance of OSA treatment with the aim of improving their compliance.
Parati, G., Pengo, M., Lombardi, C. (2019). Obstructive Sleep Apnea and Hypertension: Why Treatment Does Not Consistently Improve Blood Pressure. CURRENT HYPERTENSION REPORTS, 21(4) [10.1007/s11906-019-0935-x].
Obstructive Sleep Apnea and Hypertension: Why Treatment Does Not Consistently Improve Blood Pressure
Parati G.
;Pengo M. F.;Lombardi C.
2019
Abstract
Purpose of Review: Obstructive sleep apnea (OSA) and hypertension are two phenomena deeply linked together and, although a causal relationship has been suggested, a recent meta-analysis showed only a very modest effect of OSA treatment on blood pressure (BP). However, a vast number of randomized controlled trials published so far share some limitations, mainly of methodological nature: neither OSA nor BP is always assessed in a standardized way. Moreover, compliance with OSA treatment is often sub-optimal making the results of these trials difficult to interpret. Recent Findings: Recent studies have shown that antihypertensive drugs can reduce BP more than OSA treatment, showing a better compliance profile and very few side effects. Summary: Considering the importance of reducing the overall cardiovascular risk of OSA patients, a more careful management of patient’s antihypertensive medication could allow a better BP control also in this condition. In addition, greater efforts should be made to improve patient’s acceptance of OSA treatment with the aim of improving their compliance.File | Dimensione | Formato | |
---|---|---|---|
Parati2019_Article_ObstructiveSleepApneaAndHypert.pdf
Solo gestori archivio
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Dimensione
249.96 kB
Formato
Adobe PDF
|
249.96 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.